Pure Global AI
NCT06214208Recruiting

Influence of Spinal Stimulation Frequency on Spasticity, Motor Control, and Pain After Spinal Cord Injury

Neuromodulation of Spinal Circuits: Effects on Spasticity, Nociception, and Motor Activation (Phase II)
Shepherd Center, Atlanta GAClinicalTrials.govother
Verified
Study focus
Disease/Condition
Spinal Cord Injuries
Drug/Device/Intervention
Transcutaneous Spinal Stimulation
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Shepherd Center, Atlanta GA
Location
Atlanta, United States of America
Timeline & enrollment
Phase
N/A
Start date
Feb 19, 2024
End date
Jan 01, 2026
Enrollment
46 participants
Primary outcome

Pendulum Test

Summary

The goal of this study is to identify the effect of different types of noninvasive spinal
 stimulation on spasticity (involuntary muscle activity), muscle strength, and pain in people
 with spinal cord injury. The spinal stimulation consists of electrical stimulation applied
 through one electrode over the skin of the lower back and two electrodes over the stomach.
 Testing will include participating in measurements before the intervention, during
 intervention, and immediately after the intervention. This study requires participants to
 come into Shepherd Center 4 consecutive days a week for 2-3 hours per day across 2-3 weeks.

ICD-10 classifications
Sequelae of injury of spinal cordOther and unspecified injuries of thoracic spinal cordOther and unspecified injuries of cervical spinal cordOther injury of lumbar spinal cordInjury of spinal cord, level unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06214208
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06214208 through Pure Global AI's free database. This phase not specified trial is sponsored by Shepherd Center, Atlanta GA and is currently Recruiting. The study focuses on Spinal Cord Injuries. Target enrollment is 46 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.